Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR

This publication has 31 references indexed in Scilit:

• Long-Term Effects of Sotatercept on Right Ventricular Function
  JACC: Heart Failure, 2023
• Management of Pulmonary Arterial Hypertension
  Seminars in Respiratory and Critical Care Medicine, 2023
• Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
  Scientific Reports, 2022
• An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
  Developmental Dynamics, 2022
• Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
  The Journal of Heart and Lung Transplantation, 2022
• Sotatercept for the Treatment of Pulmonary Arterial Hypertension
  New England Journal of Medicine, 2021
• Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension
  Chest, 2021
• Epidemiology and treatment of pulmonary arterial hypertension
  Nature Reviews Cardiology, 2017
• Treatment of pulmonary arterial hypertension with targeted therapies
  Nature Reviews Cardiology, 2011
• The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension
  JACC, 1999